Key result
Cav-3 P104L reduces myofiber formation via impaired AKT signaling, whereas DeltaTFT triggers hypertrophic myotubes.
Why the study?
Separated mutations within the dystrophy-related gene caveolin-3 may cause muscle degeneration through different mechanisms, which requires investigation.
Answers are grounded in this paper and cite their sources.
Different mutations within the Caveolin-3 gene cause muscle degeneration through distinct mechanisms, highlighting mutation-specific pathophysiology in limb-girdle muscular dystrophy 1-C.
Caveolin-3 (Cav-3) is the main scaffolding protein present in myofiber caveolae. We transfected C2C12 myoblasts with dominant negative forms of Cav-3, P104L or DeltaTFT, respectively, which cause the limb-girdle muscular dystrophy 1-C. Both these forms triggered Cav-3 loss during C2C12 cell differentiation. The P104L mutation reduced myofiber formation by impaired AKT signalling, accompanied by dramatic expression of the E3 ubiquitin ligase Atrogin. On the other hand, the DeltaTFT mutation triggered hypertrophic myotubes sustained by prolonged AKT activation, but independent of increased levels of follistatin and interleukin 4 expression. These data suggest that separated mutations within the same dystrophy-related gene may cause muscle degeneration through different mechanisms.
No takes yet. Share an insight, caveat, or question.
Fanzani et al. (2007) studied Limb-girdle muscular dystrophy 1-C. Transfection with dominant negative forms of Cav-3 (P104L or DeltaTFT) was evaluated on Myofiber formation and AKT signalling. Transfection of C2C12 myoblasts with Cav-3 P104L reduced myofiber formation via impaired AKT signalling, whereas the DeltaTFT mutation triggered hypertrophic myotubes via prolonged AKT activation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: